Philanthropy & Grantmaking
(T30)
IRS Verified
DX Registered
990 on File
MICHAEL ROLFE PANCREATIC CANCER FOUNDATION
Financial strength (30%)
80/100
Reliability (20%)
55/100
Effectiveness (25%)
71/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The Rolfe Pancreatic Cancer Foundation is a 501(c)(3) public charity whose mission is to support scientific research that will lead to an early detection test for pancreatic cancer. The Foundation serves as a catalyst for the early diagnosis and ultimate cure of pancreatic cancer by funding advanced medical research, public awareness initiatives, and educational programs. The Foundation also seeks to increase the quality and quantity of emotional and psychological support services for pancreatic cancer patients and their families through partnerships with organizations that specialize in this type of care.
Financial Overview — FY 2024
$998K
Total Revenue
$736K
Total Expenses
$838K
Net Assets
5
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
69.3%
Fundraising Efficiency
35.3%
Operating Reserve
13.66x
Liability-to-Asset
12.3%
Revenue Diversification
97.0%
Executive Compensation
$127K
Compared with Peers
FY 2024
Compared with 16,645 similar organizations
(United States, Philanthropy & Grantmaking, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
69.3% | 90.2% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
15.7% | 7.9% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
15.0% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
35.3% | 7.3% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.7 mo | 95.2 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
12.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.0% | 90.4% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
18.9% | 18.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-9.6% | 6.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
26.3% | 1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $998K | $736K | $838K | 69.3% | 5 |
| 2023 | $839K | $814K | $576K | 74.3% | 5 |
| 2022 | $788K | $795K | $550K | 72.0% | 6 |
| 2021 | $785K | $678K | N/A | — | 5 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.